MassBioHub Event Hub Event

Diaceutics Talks: Rise of the Diagnostic Intelligence Layer in Successful Therapy Adoption

May 06, 2026

MassBioHub

Register Offsite
Add to Calendar + 2026-05-06 17:00 2026-05-06 20:00 America/New_York Diaceutics Talks: Rise of the Diagnostic Intelligence Layer in Successful Therapy Adoption

As diagnostic‑driven therapies advance, commercial success will be defined by those who build diagnostic advantage, ensuring the right patients are identified and treated at the right time. 

​The Diagnostic Intelligence Layer is transforming how therapies reach patients. It powers timely, in-workflow HCP action, strengthens diagnostic-driven therapy decisions and exposes diagnosis → treatment gaps using multimodal data. 

​Join Dana Sullivan, Principal Advisor for Precision Medicine Strategy, and Patrick Mullaney, Strategic Partnerships Lead, as they unpack how diagnostic intelligence is transforming therapy adoption, market readiness, and competitive edge.  

​In this session, you will learn: 

  • Why medical affairs, marketing & sales, operations, and insights & analytics teams must collaborate throughout the diagnostic pathway for every therapy. 
  • ​How diagnostic intelligence uncovers real-time indicators, systemic gaps, and growth opportunities, enabling earlier, more effective intervention.  
  • ​How HCP engagement must move beyond the linear funnel toward timely, context‑driven interactions delivered at the point of decision‑making. 
  • ​How leading biotech and pharma brands are gaining competitive edge by shaping, not just reacting to, the diagnostic ecosystem around their therapies.

​We’d love for you to be there as we explore the rise of the Diagnostic Intelligence Layer and why it is becoming the strategic backbone for HCP activation, therapy adoption, and market growth in 2026 and beyond. 

Who should attend:

  • Biotech and pharma leaders
  • Marketing managers
  • Commercial leaders
  • Medical affairs
  • Data & insights

​Agenda: 

​Join Diaceutics for an energising evening session at the MassBioHub Conference Centre. An opportunity to learn, connect, and unwind with peers. 

​Arrival & Welcome – 5pm 

​Settle in, grab a drink, and meet fellow attendees as we kick things off. 

​Diaceutics Presentation – 6pm 

​A dynamic session exploring the rise of the Diagnostic Intelligence Layer, followed by an open discussion and audience Q&A. 

​Networking, Nibbles & Drinks – 7pm 

​Stay for relaxed conversation, light bites, and beverages on us, the perfect way to wrap up the evening. 

MassBioHub, Boston, 700 Technology Square, 5th Floor

As diagnostic‑driven therapies advance, commercial success will be defined by those who build diagnostic advantage, ensuring the right patients are identified and treated at the right time. 

​The Diagnostic Intelligence Layer is transforming how therapies reach patients. It powers timely, in-workflow HCP action, strengthens diagnostic-driven therapy decisions and exposes diagnosis → treatment gaps using multimodal data. 

​Join Dana Sullivan, Principal Advisor for Precision Medicine Strategy, and Patrick Mullaney, Strategic Partnerships Lead, as they unpack how diagnostic intelligence is transforming therapy adoption, market readiness, and competitive edge.  

​In this session, you will learn: 

  • Why medical affairs, marketing & sales, operations, and insights & analytics teams must collaborate throughout the diagnostic pathway for every therapy. 
  • ​How diagnostic intelligence uncovers real-time indicators, systemic gaps, and growth opportunities, enabling earlier, more effective intervention.  
  • ​How HCP engagement must move beyond the linear funnel toward timely, context‑driven interactions delivered at the point of decision‑making. 
  • ​How leading biotech and pharma brands are gaining competitive edge by shaping, not just reacting to, the diagnostic ecosystem around their therapies.

​We’d love for you to be there as we explore the rise of the Diagnostic Intelligence Layer and why it is becoming the strategic backbone for HCP activation, therapy adoption, and market growth in 2026 and beyond. 

Who should attend:

  • Biotech and pharma leaders
  • Marketing managers
  • Commercial leaders
  • Medical affairs
  • Data & insights

​Agenda: 

​Join Diaceutics for an energising evening session at the MassBioHub Conference Centre. An opportunity to learn, connect, and unwind with peers. 

​Arrival & Welcome – 5pm 

​Settle in, grab a drink, and meet fellow attendees as we kick things off. 

​Diaceutics Presentation – 6pm 

​A dynamic session exploring the rise of the Diagnostic Intelligence Layer, followed by an open discussion and audience Q&A. 

​Networking, Nibbles & Drinks – 7pm 

​Stay for relaxed conversation, light bites, and beverages on us, the perfect way to wrap up the evening. 

See all Member Events